Abstract:Structure-based virtual screening of binding of candidate drug molecules is a topic of increasing interest in the discovery of small molecule drugs. As the same drug molecule may bind to different binding sites on a target protein, the binding site selectivity that is related to the binding tendency of candidate drug molecules to different binding sites after reaching the target protein need to be considered in sufficient details. In this work, a systematic and computer-aided virtual screening framework based on the binding site selectivity to screen candidate drug molecules in terms of their ability to bind on selected sites is presented. The framework integrates two machine learning (ML)-based models to predict the binding potential and binding selectivity to specific binding sites that are important for virtual screening of drug molecules. The details of the ML-based models together with the work-flow of the computer-aided virtual screening methods and the efficient and consistent integration of related drug design tools are presented. The applicability of this virtual screening framework is illustrated through a case study involving the screening for drug molecules as inhibitors to block the binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to angiotensin converting enzyme 2 (ACE2), which is the target protein. The case study results point to identification of new candidate inhibitors with better binding site selectivity than two known potential inhibitors, Nilotinib and SSAA09E2.

Virtual Screening in Small Molecule Discovery for Epigenetic Targets

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

[Advancements in virtual screening techniques for study of enzyme inhibitor compounds]

Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors

Molecular Docking‐based Virtual Screening and Dynamics Simulation Study of Novel and Potential SIRT7 Inhibitors

Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors

A Virtual Screening Framework Based on the Binding Site Selectivity for Small Molecule Drug Discovery

Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development

Virtual Screening Methods As Tools For Drug Lead Discovery From Large Chemical Libraries

Virtual Screening Methods As Tools for Drug Lead Discovery from Large Chemical Libraries.

Epigenetic Regulation and Drug Discovery for Cancer Therapy.

Epigenetic targets and drug discovery: part 1: histone methylation.

Computer-Aided Drug Design in Epigenetics

Network Medicine: A Potential Approach for Virtual Drug Screening

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors

Deep Neural Network Classifier for Virtual Screening Inhibitors of (S)-Adenosyl-l-methionine (Sam)-Dependent Methyltransferase Family

Virtual Screening and Experimental Validation of Novel Histone Deacetylase Inhibitors

Small Molecular Drug Screening Based on Clinical Therapeutic Effect

Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.

Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery

Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies